Traditional viral vaccine production uses a trans-bottle culture process with adherent cells. This technique has the disadvantages of being limited by cell growth and cell density, low viral yield, high costs, and intensive labor. With the advancement of modern biotechnology and technical innovation from leading vaccine manufacturers, the drift towards applications involving suspension cell culture technologies for viral vaccine production has become an inevitable trend. JSBio has independent intellectual property rights of the suspension cell culture process development platform we use, which can provide overall solutions for vaccine manufacturers. These services pave the way for technological innovation in the industry, enterprise transformation, and upgrading.
Extensive project experience
Serum-free, chenmically defined media with independent intellectual property rights to shorten the domestication time and achieve one-step serum removal
Application to a variety of cell lines
A variety of mammalian cell lines have been successfully adapted to suspension cell growth using our technology
Matching serum-free media and chemically defined media
Disposable RotaTek Bioreactor Process scale up service
JSBio offers a suspension cell process development platform where we will adapt the client’s adherent cells to suspension growth and provide cell line development services for these cells.
Cell banking (standard formulation or custom formulation)
Adherent cell adaption to suspension growth (standard formulation or custom formulation)
Process development using a shaker platform, monitoring cell
Growth and virus production (Cell and viral growth media and process optimization)
Small scale process, 2 L Bioreactor
Pilot scale process, 50 - 200 L Bioreactor
Adherent cell lines(such as MRC-5, Vero etc.) can be used for vaccine production. JSBio can provide the following micro-carrier adherence cell platform services:
Matching low or serum free media
Micro-carrier process and scale up services
Suspension Cells | Cell Medium | Application |
MDCK | Human influenza virus vaccine, avian influenza, swine flu, and other veterinary virus vaccines | |
HEK293 | CD HEK293 374 | Suspension adaptation of adherent HEK293 cells and subsequent passage expansion of cells |
HEK293 | Cell growth and adenoviral expansion in HEK293 and 293F suspension cells | |
Expi293F and HEK293 | Cell growth and adenoviral expansion in Expi293F | |
Insect Cells | Insect cell growth and baculovirus Expansion | |
EB66 | Broad-spectrum veterinary virus vaccines such as poultry vaccine | |
ST | Swine fever, porcine epidemic diarrhea, porcine infectious gastroenteritis, pseudorabies and other veterinary virus vaccines | |
MDBK | Veterinary viral vaccines such as bovine infectious rhinotracheitis and bovine viral diarrhea | |
PK-15 | Pig ring, porcine infectious gastroenteritis, porcine parietal, pseudorabies and other veterinary virus vaccines | |
BHK-21 | Foot-and-mouth disease, Newcastle disease, bovine epidemic fever, pseudorabies and other veterinary virus vaccines |